We value your privacy

We use cookies to analyze site usage and improve your experience. You can accept all, reject non-essential, or customize. See our Privacy Policy.

Perimenopause · 6 min read

Understanding perimenopause: the years before menopause

By Kevin Wolfe, Founder & CEO

Reviewed by Kindr Health Clinical Team

Published · Updated

Perimenopause can begin in your late 30s or 40s and last up to a decade. Here is what is happening hormonally and what actually helps.

Perimenopause is the transition period before menopause — the years in which your ovaries gradually produce less estrogen and progesterone, and your menstrual cycles begin to change. For most women it begins in the mid-40s, but it can start as early as the mid-30s and last anywhere from four to ten years before menopause is reached (defined clinically as twelve consecutive months without a period).

What is happening hormonally

During perimenopause, estrogen does not decline in a smooth line. It fluctuates — often wildly. Levels can spike well above normal one month and crash the next. Progesterone, by contrast, tends to fall earlier and more steadily as ovulation becomes inconsistent. This mismatch is what drives many of the symptoms women experience: it is not low estrogen alone, it is the volatility.

Common symptoms

  • Irregular periods — shorter, longer, heavier, or skipped
  • Sleep disruption, particularly waking at 3 a.m.
  • New or worsening anxiety
  • Brain fog and difficulty concentrating
  • Hot flashes or night sweats
  • Mood swings, irritability, or low mood
  • Decreased libido
  • Joint aches, heart palpitations, and changes in skin and hair

Why most labs come back "normal"

Standard hormone panels measure a single moment in time. In perimenopause, your levels can be normal on the day of the draw and abnormal a week later. This is why so many women are told their labs look fine while their symptoms are severe. A clinician trained in menopause medicine evaluates your full symptom picture, your cycle history, and your trajectory over time — not just one number on one day.

What actually helps

For most healthy women in perimenopause, the most effective treatment is hormone therapy — typically a combination of estradiol and micronized progesterone tailored to where you are in the transition. The 2022 NAMS Position Statement and ACOG both support hormone therapy as first-line treatment for moderate-to-severe vasomotor symptoms in women under 60 or within 10 years of menopause onset, including those still cycling. Lifestyle measures — protected sleep, strength training, and protein-forward nutrition — meaningfully amplify the effect but rarely substitute for it.

When to start care

There is no benefit to suffering through perimenopause. If your symptoms are affecting your sleep, your mood, your work, or your relationships, that is reason enough to speak with a clinician who specializes in this transition. The earlier you build the right protocol, the smoother the next several years will be.

Sources

Medically reviewed by Kindr Health Clinical Team
Last updated: May 10, 2026

More on hrt basics

Continue across the Kindr entity graph

Related evidence, peptides, and clinical tools on the same topic.

This content is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Keep reading

Research

Who shouldn't take hormone therapy? Contraindications, gray areas, and your non-hormonal options.

A recent conference presentation found that hormone therapy prescribing despite a documented contraindication is rising in primary care. Here's what current FDA labels list as contraindications, where an individualized discussion comes in, and which nonhormonal options a major guideline suggests.

Research

Is there an age limit on hormone therapy? Timing, the 10-year window, and HT after 60 and 65.

A SWAN analysis and current FDA and ACOG guidance frame hormone therapy around timing and individual history, not a single age cutoff. Here's what that means for starting, continuing after 60 or 65, and what to ask a clinician.

Research

Strong through menopause: why muscle matters, especially if you're on a GLP-1

A trial of 120 midlife adults on tirzepatide found that lifting three times a week reduced lean-tissue loss and raised strength, with similar weight loss. Here's what that means if you're navigating menopause, and what to discuss with your clinician before you start.

Explore your next step

Kindr Care is being updated, and the exact clinical process will depend on the current care pathway.

Explore care options →